{"id":"W2922015761","doi":"10.1200/jco.2019.37.7_suppl.377","title":"Mature results from EV-101: A phase I study of enfortumab vedotin in patients with metastatic urothelial cancer (mUC).","year":2019,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"ca_institutions":"Baker Hughes (Canada); Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Internal medicine; Tolerability; Gastroenterology; Cancer; Anemia; Chemotherapy; Bladder cancer; Oncology; Adverse effect","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001020242,0.000678828,0.0008412612,0.0001705105,0.0002494658,0.0007738921,0.0004709063,0.0007490342,0.003480248],"category_scores_gemma":[0.0006057578,0.0002559073,0.0008542389,0.0001991423,0.0002876198,0.0004137101,0.0002095615,0.001680498,0.0008360831],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005847162,"about_ca_system_score_gemma":0.0007839798,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006753162,"about_ca_topic_score_gemma":0.001738522,"domain_scores_codex":[0.9997898,0.00009341344,0.00001451613,0.00002523172,0.00003363849,0.00004343172],"domain_scores_gemma":[0.9996794,0.00005779369,0.00005081883,0.00002773183,0.00002568645,0.0001585121],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.3137642,0.07306827,0.02907163,0.00266686,0.002753778,0.001537655,0.0007428435,0.006201081,0.1250266,0.0007239566,0.02228469,0.4221584],"study_design_scores_gemma":[0.2712815,0.6070716,0.06663628,0.000225523,0.001313344,0.002637938,0.0001973759,0.002946208,0.01976543,0.0004218868,0.0274278,0.0000750879],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9838237,0.005973617,0.0007476077,0.0007478028,0.0001310483,0.0014825,0.002178273,0.0001022778,0.004813191],"genre_scores_gemma":[0.9820735,0.003227555,0.001343882,0.001359001,0.0001087792,0.000996568,0.006431504,0.00003897279,0.004420291],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003480248,"threshold_uncertainty_score":0.01164263,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07501301366022906,"score_gpt":0.4548400277273009,"score_spread":0.3798270140670718,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}